Cargando…
Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis
BACKGROUND: CA-CDI accounts for up to 50% of all CDIs. Case–control studies (CCS) have been used to estimate the odds ratio (OR) of CA-CDI associated with antibiotic exposure. These ORs demonstrate significant heterogeneity across studies. Unlike CCS, a self-controlled case series (SCCS) design can...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631195/ http://dx.doi.org/10.1093/ofid/ofx163.996 |
_version_ | 1783269390950596608 |
---|---|
author | DiDiodato, Giulio Fruchter, Lauren |
author_facet | DiDiodato, Giulio Fruchter, Lauren |
author_sort | DiDiodato, Giulio |
collection | PubMed |
description | BACKGROUND: CA-CDI accounts for up to 50% of all CDIs. Case–control studies (CCS) have been used to estimate the odds ratio (OR) of CA-CDI associated with antibiotic exposure. These ORs demonstrate significant heterogeneity across studies. Unlike CCS, a self-controlled case series (SCCS) design can be used to control for all time-invariant confounders leading to less biased effect estimates. METHODS: Adults (≥18 years) registered (N = 139,670) with the Barrie and Community Family Health Team (BCFHT) were included in the study. Cases were defined as any patient with an incident case of CA-CDI and ≥1 antibiotic exposure occurring between January 1, 2011 and December 31, 2016. The SCCS model was used to estimate the association between antibiotic exposure and CA-CDI. The SCCS model yields estimates of the relative incidence rate of CA-CDI in exposure periods relative to non-exposure periods within a case. Exposure periods were defined as starting two days after any antibiotic prescription and ending 60 days later. Multiple exposure periods and time-varying confounders due to calendar year were included in the final model. The relative incidence rate ratio (IRR) was estimated using conditional poisson regression analysis. Proton pump inhibitor (PPI) use was included as an effect modifier. Antibiotics were divided into high-risk (fluoroquinolone, clindamycin, and cephalosporin) and low-risk exposures. Research ethics approval was obtained from the BFCHT research ethics board. RESULTS: Among 544 total CDI cases, N = 189 CA-CDI cases met the inclusion criteria. Any antibiotic exposure increases the risk by ≥2-fold, with no difference observed between high and low-risk groups (IRR=1.11, 95% CI 0.53–2.36) (Table 1). CONCLUSION: Antibiotic exposure increases the risk of CA-CDI, with IRR estimates similar to those observed for healthcare-associated-CDI. This, along with the control of all time-invariant confounders by the SCCS method suggests a less biased effect estimate previously reported from CCS. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-5631195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56311952017-11-07 Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis DiDiodato, Giulio Fruchter, Lauren Open Forum Infect Dis Abstracts BACKGROUND: CA-CDI accounts for up to 50% of all CDIs. Case–control studies (CCS) have been used to estimate the odds ratio (OR) of CA-CDI associated with antibiotic exposure. These ORs demonstrate significant heterogeneity across studies. Unlike CCS, a self-controlled case series (SCCS) design can be used to control for all time-invariant confounders leading to less biased effect estimates. METHODS: Adults (≥18 years) registered (N = 139,670) with the Barrie and Community Family Health Team (BCFHT) were included in the study. Cases were defined as any patient with an incident case of CA-CDI and ≥1 antibiotic exposure occurring between January 1, 2011 and December 31, 2016. The SCCS model was used to estimate the association between antibiotic exposure and CA-CDI. The SCCS model yields estimates of the relative incidence rate of CA-CDI in exposure periods relative to non-exposure periods within a case. Exposure periods were defined as starting two days after any antibiotic prescription and ending 60 days later. Multiple exposure periods and time-varying confounders due to calendar year were included in the final model. The relative incidence rate ratio (IRR) was estimated using conditional poisson regression analysis. Proton pump inhibitor (PPI) use was included as an effect modifier. Antibiotics were divided into high-risk (fluoroquinolone, clindamycin, and cephalosporin) and low-risk exposures. Research ethics approval was obtained from the BFCHT research ethics board. RESULTS: Among 544 total CDI cases, N = 189 CA-CDI cases met the inclusion criteria. Any antibiotic exposure increases the risk by ≥2-fold, with no difference observed between high and low-risk groups (IRR=1.11, 95% CI 0.53–2.36) (Table 1). CONCLUSION: Antibiotic exposure increases the risk of CA-CDI, with IRR estimates similar to those observed for healthcare-associated-CDI. This, along with the control of all time-invariant confounders by the SCCS method suggests a less biased effect estimate previously reported from CCS. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631195/ http://dx.doi.org/10.1093/ofid/ofx163.996 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts DiDiodato, Giulio Fruchter, Lauren Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis |
title | Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis |
title_full | Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis |
title_fullStr | Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis |
title_full_unstemmed | Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis |
title_short | Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis |
title_sort | antibiotic exposure and risk of community-associated clostridium difficile infection (ca-cdi): a self-controlled case series analysis |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631195/ http://dx.doi.org/10.1093/ofid/ofx163.996 |
work_keys_str_mv | AT didiodatogiulio antibioticexposureandriskofcommunityassociatedclostridiumdifficileinfectioncacdiaselfcontrolledcaseseriesanalysis AT fruchterlauren antibioticexposureandriskofcommunityassociatedclostridiumdifficileinfectioncacdiaselfcontrolledcaseseriesanalysis |